Similar Articles
1331 Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma
1332 Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection
1333 Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence
1334 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma
1335 Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients
1336 Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study
1337 Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
1338 Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: Dysregulation and implications for early detection, diagnosis and therapy
1339 “Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China
1340 MDCT imaging following nephrectomy for renal cell carcinoma: Protocol optimization and patterns of tumor recurrence
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA